NJ A4184

Prohibits manufacturers and wholesale distributors from engaging in "price gouging" on essential off-patent or generic prescription drugs and biological products sold in New Jersey

Defines price gouging as price increases exceeding 50% within one year when the wholesale acquisition cost exceeds $80 for a 30-day supply or full course of treatment, and the increase is not justified by production costs or public health access expansion

Applies to drugs on the WHO Model List of Essential Medicines or designated essential by the Commissioner of Health, with expired patent protections, and manufactured by three or fewer companies

Authorizes the Attorney General to require manufacturers to submit cost documentation within 45 days, seek court orders to compel compliance, and assess civil penalties up to $10,000 per sale constituting a violation

Takes effect seven months after enactment, with the Division of Consumer Affairs responsible for implementing regulations